REGN

#169
Regeneron Pharmaceuticals Inc
781.67
+3.42%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
781.24
781.67
Jahresspanne
476.48
821.11
Tagesänderung
+3.42%
Monatliche Änderung
+2.16%
6 month change
+33.29%
Jahresänderung
+11.19%
Vorheriger Schlusskurs
755.82
Open
781.24
Bid
Ask
Low
781.24
High
781.67
Volumen
288
Open full chart

Financials

Overview Finanzbericht Statistics Dividends
Quarterly Annual
  • Market Capitalization 81.76 B
  • Employee 15 K
  • Founded 1988
  • CEO Leonard Schleifer
  • Website www.regeneron.com
  • Headquarter New York, United States
  • FIGI BBG000C734W3
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
18.61
Price to sales ratio
5.84
Dividends per share
—
Dividend yield %
—

Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap.

Nachrichten